CAESAREA, Israel, March 27, 2017 /PRNewswire/ -- DarioHealth Corp.
(NASDAQ: DRIO), a leading global digital health company with mobile
health and big data solutions, today announced that it is now
offering a 3rd party insurance coverage option for U.S.
consumers who want to have their DarioHealth products reimbursed by
insurance.
DarioHealth has signed strategic alliance agreements with
partners across the U.S. who will be able to verify insurance
coverage benefits, and if approved, will supply and bill the
customer's insurance for their Dario™ Blood Glucose Monitoring
System and test strip supplies. During DarioHealth's pilot phase of
this insurance coverage option, partners were able to verify
benefits for customers covered by Aetna and various Blue Cross Blue
Shield plans.
Erez Raphael, Chairman and CEO of
DarioHealth, commented on the announcement: "We are extremely
excited with this new opportunity and will continue seeking out
partnerships to expand our insurance coverage reach. Our customers
asked about this, and we are happy to be able to provide this
option to them. Many of these customers are already paying
significant out of pocket cost for a variety of healthcare needs,
so lowering their financial burden is tremendously gratifying and a
big win for everyone in our community."
With today's announcement, customers will have the ability –
exclusively through DarioHealth's website store – to inquire about
3rd party reimbursement of the company's products, which
until now were only available to U.S.-based customers who paid out
of pocket for DarioHealth's products.
DarioHealth plans to expand its reach and add additional
providers and insurance coverage options for those who want to
utilize the insurance benefits available to them.
About DarioHealth Corp.
DarioHealth Corp. is a leading global digital health company
serving tens of thousands of users with dynamic mobile health
solutions. We believe people deserve the best tools to manage their
treatment, and harnessing big data, we have developed a unique way
for our users to analyze and personalize their diabetes management.
With our smart diabetes solution, users have direct access to track
and monitor all facets of diabetes, without having the disease slow
them down. The acclaimed Dario™ Blood Glucose Monitoring System
all-in-one blood glucose meter and native smartphone app gives
users an unrivaled method for self-diabetes management. DarioHealth
is headquartered in Caesarea,
Israel with a regional office in Burlington, Massachusetts. For more
information, visit http://mydario.investorroom.com/.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and
partners of DarioHealth Corp. (the "Company") related thereto
contain or may contain forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Statements that are not statements of historical fact may be deemed
to be forward-looking statements. Without limiting the generality
of the foregoing, words such as "plan," "project," "potential,"
"seek," "may," "will," "expect," "believe," "anticipate," "intend,"
"could," "estimate," or "continue" are intended to identify
forward-looking statements. For example, when the Company
describes that it continues to seek out insurance providers and
partnerships to expand its insurance coverage benefits, and the
potential for Aetna and Blue Cross Blue Shield to serve as
insurance provides for such purposes, it is using forward-looking
statements. Readers are cautioned that certain important factors
may affect the Company's actual results and could cause such
results to differ materially from any forward-looking statements
that may be made in this news release. Factors that may affect the
Company's results include, but are not limited to, regulatory
approvals, product demand, market acceptance, impact of competitive
products and prices, product development, commercialization or
technological difficulties, the success or failure of negotiations
and trade, legal, social and economic risks, and the risks
associated with the adequacy of existing cash resources. Additional
factors that could cause or contribute to differences between the
Company's actual results and forward-looking statements include,
but are not limited to, those risks discussed in the Company's
filings with the U.S. Securities and Exchange Commission. Readers
are cautioned that actual results (including, without limitation,
the timing for and results of the Company's commercial and
regulatory plans for Dario™) may differ significantly from those
set forth in the forward-looking statements. The Company undertakes
no obligation to publicly update any forward-looking statements,
whether as a result of new information, future events or otherwise,
except as required by applicable law.
DarioHealth Corporate and Media Contact
Shmuel Herschberg
Marketing Director
shmuel@mydario.com
+1-800-896-9062
DarioHealth Investor Relations Contact
Hayden IR
Rob Fink / Brett Maas
DRIO@HaydenIR.com
+1-646-415-8972 / +1-646-536-7331
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/dariohealth-launches-insurance-coverage-option-for-us-consumers-300429551.html
SOURCE DarioHealth Corp.